Medical Blog About Treatment Abroad
Welcome to our medical blog – it is dedicated to empowering patients with knowledge about global healthcare! We created this platform with the intention to bridge the gap between patients and the medical innovations available globally.
What's Inside: Discover new and rare methods in oncology, immunology, heart surgery, neurosurgery, and other medical fields! Our health travel insights show how medical journeys open new possibilities with advanced treatments unavailable locally, including specialized cancer care abroad.
Who Benefits: This resource is for patients and their families who seek new treatment methods and explore options at leading international hospitals. Those who want to make informed healthcare decisions beyond borders.
Why Read: Booking Health experts provide verified information through patient-friendly articles – they translate complex medical advances into accessible info. Stay current with the latest developments in global healthcare and discover how international medicine can transform treatment outcomes!
Browse our latest articles and take the first step toward better health outcomes!
Latest posts
New Effective Treatments for Stage 4 Cancer: Innovations in Oncology
According to official statistics from the WHO in 2022, oncological diseases are now the cause of one in every six deaths worldwide. This has encouraged the international medical community to develop new advanced stage 4 cancer treatment methods and increase the effectiveness of the already existing ones. This is particularly important for...
Lutetium‑177 PSMA Therapy for Prostate Cancer
Prostate cancer ranks as one of the most widespread cancer types in men across the globe and continues to be a major reason for cancer-related deaths. The Global Cancer Observatory (GLOBOCAN) reports that doctors diagnosed over 1.4 million new cases of prostate cancer in 2020, making it the second most common cancer in men after...
Comprehensive Guide to Stage 4 Prostate Cancer: Treatment Options
Prostate cancer (PC) is the most common type of cancer in men and one of the main causes of death in developed countries of Europe and North America. The incidence of it has risen annually by 3% since 2014. Prostate cancer is the second-leading cause of death among males in the US. According to the American Cancer Society, about 1 in...
Dendritic Cell Vaccine for Glioblastoma
Standard therapy for glioblastoma is the combination of surgical removal of the tumor, chemo- or radiation therapy. Average life expectancy after diagnosis with standard treatment of glioblastoma is 15-17 months, and the 5-year survival rate does not exceed 5-10%. Today, supplementing the standard treatment protocol with innovative...
Cervical cancer treatment with dendritic cell therapy
Cervical cancer affects approximately 660,000 women worldwide each year, making it the fourth most common cancer among women globally. While early detection typically offers excellent cure rates, advanced cases require innovative treatment approaches. Dendritic cell therapy represents a promising personalized immunotherapy...
Transarterial Chemoembolization (TACE)
Transarterial Chemoembolization (TACE) is one of the most widely used and effective minimally invasive treatments for liver tumors and other cancers with localized blood supply. As technology and oncology have evolved, TACE has become even more precise and personalized in 2025, offering patients new hope - especially when surgery...
Immunotherapy for Cancer
Immune-based therapy is an innovative method of cancer treatment, and one of the most promising innovations is dendritic cell therapy. This radical approach utilizes the strength of the patient's immune system to attack carcinoma and destroy tumor cells. The 2011 Nobel Prize in Medicine, awarded to Ralph M. Steinman as a discoverer...
Cancer Treatment in Germany
One or two decades ago, a cancer diagnosis was almost equated to death. Nowadays, due to the fast development of healthcare, numerous oncological diseases can be cured. Nevertheless, the cancer burden is still high in Europe. The European Cancer Information System (ECIS) states that in 2022 around 4.1 million new cases of cancer were...
